Lee Dittrich, MD
NPI 1316905862 · Dermatology Physician · Knoxville, TN
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Lee Dittrich, MD is a Dermatology Physician provider in Knoxville, TN (NPI 1316905862).
Provider details
- NPI number
- 1316905862
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 36383 (TN)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
8,309 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 3,604 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,330 | $85 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 959 | $42 |
| Destruction of Skin Growth, 1-14 Growths17110 | 703 | $100 |
| Biopsy of Related Skin Growth, First Growth11102 | 584 | $70 |
| Biopsy of Related Skin Growth, Each Additional Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 135 | 78 |
| Triamcinolone Acetonide | 111 | 85 |
| Betamethasone Dipropionate | 85 | 40 |
| Hydrocortisone | 60 | 47 |
| Mupirocin | 54 | 47 |
| Clobetasol Propionate | 54 | 28 |
| Valacyclovir Hclbrand: Valacyclovir | 53 | 19 |
| Fluorouracil | 44 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,887 across 91 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-05-03
- Last updated
- 2026-04-02
- Certified
- 2026-04-02
Frequently asked questions
- What is Lee Dittrich's NPI number?
- Lee Dittrich's National Provider Identifier (NPI) is 1316905862, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Lee Dittrich's specialty?
- Lee Dittrich is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Lee Dittrich located?
- Lee Dittrich's practice location on file with NPPES is 123 Fox Rd, Knoxville, TN 37922-3369.
- What is Lee Dittrich's phone number?
- The practice phone number listed in the NPPES registry for Lee Dittrich is (865) 690-9467.
- Does Lee Dittrich accept Medicare?
- Lee Dittrich is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Lee Dittrich's NPI active?
- Yes — Lee Dittrich's NPI (1316905862) is active in the NPPES registry as of the last update on 2026-04-02.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.